{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:47:48Z","timestamp":1785257268426,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s10072-023-07256-z","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T02:02:19Z","timestamp":1705111339000},"page":"2615-2623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Correlation between serum biomarkers, brain volume, and retinal neuronal loss in early-onset Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Ziyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Robert","family":"Kwapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6932-0131","authenticated-orcid":false,"given":"Shuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"key":"7256_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","volume":"21","author":"T Ayodele","year":"2021","unstructured":"Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C (2021) Early-onset Alzheimer\u2019s disease: what is missing in research? Curr Neurol Neurosci Rep 21:4. https:\/\/doi.org\/10.1007\/s11910-020-01090-y","journal-title":"Curr Neurol Neurosci Rep"},{"key":"7256_CR2","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1038\/s41380-022-01531-9","volume":"27","author":"DW Sirkis","year":"2022","unstructured":"Sirkis DW, Bonham LW, Johnson TP, La Joie R, Yokoyama JS (2022) Dissecting the clinical heterogeneity of early-onset Alzheimer\u2019s disease. Mol Psychiatry 27:2674\u20132688. https:\/\/doi.org\/10.1038\/s41380-022-01531-9","journal-title":"Mol Psychiatry"},{"key":"7256_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1212\/CON.0000000000000687","volume":"25","author":"MF Mendez","year":"2019","unstructured":"Mendez MF (2019) Early-onset Alzheimer disease and its variants. Continuum (Minneap Minn) 25:34\u201351. https:\/\/doi.org\/10.1212\/CON.0000000000000687","journal-title":"Continuum (Minneap Minn)"},{"key":"7256_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1017\/S1041610214001173","volume":"26","author":"K Stanley","year":"2014","unstructured":"Stanley K, Walker Z (2014) Do patients with young onset Alzheimer\u2019s disease deteriorate faster than those with late onset Alzheimer\u2019s disease? A review of the literature. Int Psychogeriatr 26:1945\u20131953. https:\/\/doi.org\/10.1017\/S1041610214001173","journal-title":"Int Psychogeriatr"},{"key":"7256_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-132273","volume":"41","author":"H Eriksson","year":"2014","unstructured":"Eriksson H et al (2014) Differences in routine clinical practice between early and late onset Alzheimer\u2019s disease: data from the Swedish Dementia Registry (SveDem). J Alzheimers Dis 41:411\u2013419. https:\/\/doi.org\/10.3233\/JAD-132273","journal-title":"J Alzheimers Dis"},{"key":"7256_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/alz.12006","volume":"16","author":"J Alber","year":"2020","unstructured":"Alber J et al (2020) Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: what we know, what we don\u2019t, and how to move forward. Alzheimers Dement 16:229\u2013243. https:\/\/doi.org\/10.1002\/alz.12006","journal-title":"Alzheimers Dement"},{"key":"7256_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/alz.12179","volume":"17","author":"PJ Snyder","year":"2021","unstructured":"Snyder PJ et al (2021) Retinal imaging in Alzheimer\u2019s and neurodegenerative diseases. Alzheimers Dement 17:103\u2013111. https:\/\/doi.org\/10.1002\/alz.12179","journal-title":"Alzheimers Dement"},{"key":"7256_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0006-8993(89)90653-7","volume":"501","author":"JC Blanks","year":"1989","unstructured":"Blanks JC, Hinton DR, Sadun AA, Miller CA (1989) Retinal ganglion cell degeneration in Alzheimer\u2019s disease. Brain Res 501:364\u2013372. https:\/\/doi.org\/10.1016\/0006-8993(89)90653-7","journal-title":"Brain Res"},{"key":"7256_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJM198608213150804","volume":"315","author":"DR Hinton","year":"1986","unstructured":"Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer\u2019s disease. N Engl J Med 315:485\u2013487. https:\/\/doi.org\/10.1056\/NEJM198608213150804","journal-title":"N Engl J Med"},{"key":"7256_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ceo.12386","volume":"43","author":"HA Bayhan","year":"2015","unstructured":"Bayhan HA, Aslan Bayhan S, Celikbilek A, Tan\u0131k N, G\u00fcrdal C (2015) Evaluation of the chorioretinal thickness changes in Alzheimer\u2019s disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol 43:145\u2013151. https:\/\/doi.org\/10.1111\/ceo.12386","journal-title":"Clin Exp Ophthalmol"},{"key":"7256_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","volume":"126","author":"VTT Chan","year":"2019","unstructured":"Chan VTT et al (2019) Spectral-domain OCT measurements in Alzheimer\u2019s disease: a systematic review and meta-analysis. Ophthalmology 126:497\u2013510. https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.009","journal-title":"Ophthalmology"},{"key":"7256_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-141659","volume":"45","author":"CY Cheung","year":"2015","unstructured":"Cheung CY et al (2015) Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis 45:45\u201356. https:\/\/doi.org\/10.3233\/JAD-141659","journal-title":"J Alzheimers Dis"},{"key":"7256_CR13","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3233\/jad-160886","volume":"56","author":"L Ferrari","year":"2017","unstructured":"Ferrari L et al (2017) Optical coherence tomography reveals retinal neuroaxonal thinning in frontotemporal dementia as in Alzheimer\u2019s disease. J Alzheimers Dis 56:1101\u20131107. https:\/\/doi.org\/10.3233\/jad-160886","journal-title":"J Alzheimers Dis"},{"key":"7256_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.archger.2014.10.011","volume":"60","author":"L Gao","year":"2015","unstructured":"Gao L, Liu Y, Li X, Bai Q, Liu P (2015) Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer\u2019s disease. Arch Gerontol Geriatr 60:162\u2013167. https:\/\/doi.org\/10.1016\/j.archger.2014.10.011","journal-title":"Arch Gerontol Geriatr"},{"key":"7256_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13195-019-0516-x","volume":"11","author":"J den Haan","year":"2019","unstructured":"den Haan J et al (2019) Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer\u2019s disease. Alzheimers Res Ther 11:62. https:\/\/doi.org\/10.1186\/s13195-019-0516-x","journal-title":"Alzheimers Res Ther"},{"key":"7256_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10072-014-2055-3","volume":"36","author":"EO Oktem","year":"2015","unstructured":"Oktem EO et al (2015) The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci 36:1141\u20131146. https:\/\/doi.org\/10.1007\/s10072-014-2055-3","journal-title":"Neurol Sci"},{"key":"7256_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","volume":"6","author":"J den Haan","year":"2017","unstructured":"den Haan J, Verbraak FD, Visser PJ, Bouwman FH (2017) Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis. Alzheimers Dement (Amst) 6:162\u2013170. https:\/\/doi.org\/10.1016\/j.dadm.2016.12.014","journal-title":"Alzheimers Dement (Amst)"},{"key":"7256_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.dadm.2017.10.005","volume":"10","author":"J den Haan","year":"2018","unstructured":"den Haan J et al (2018) Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer\u2019s disease and controls. Alzheimers Dement (Amst) 10:49\u201355. https:\/\/doi.org\/10.1016\/j.dadm.2017.10.005","journal-title":"Alzheimers Dement (Amst)"},{"key":"7256_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE et al (2022) Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol 21:66\u201377. https:\/\/doi.org\/10.1016\/S1474-4422(21)00361-6","journal-title":"Lancet Neurol"},{"key":"7256_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15:673\u2013684. https:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"key":"7256_CR21","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","volume":"17","author":"AM Brickman","year":"2021","unstructured":"Brickman AM et al (2021) Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study. Alzheimers Dement 17:1353\u20131364. https:\/\/doi.org\/10.1002\/alz.12301","journal-title":"Alzheimers Dement"},{"key":"7256_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/JAD-220673","volume":"90","author":"C Xu","year":"2022","unstructured":"Xu C, Zhao L, Dong C (2022) A review of application of Abeta42\/40 ratio in diagnosis and prognosis of Alzheimer\u2019s disease. J Alzheimers Dis 90:495\u2013512. https:\/\/doi.org\/10.3233\/JAD-220673","journal-title":"J Alzheimers Dis"},{"key":"7256_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","volume":"26","author":"TK Karikari","year":"2021","unstructured":"Karikari TK et al (2021) Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer\u2019s Disease Neuroimaging Initiative. Mol Psychiatry 26:429\u2013442. https:\/\/doi.org\/10.1038\/s41380-020-00923-z","journal-title":"Mol Psychiatry"},{"key":"7256_CR24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3233\/JAD-200043","volume":"77","author":"R Santangelo","year":"2020","unstructured":"Santangelo R et al (2020) Neuro-retina might reflect Alzheimer\u2019s disease stage. J Alzheimers Dis 77:1455\u20131468. https:\/\/doi.org\/10.3233\/JAD-200043","journal-title":"J Alzheimers Dis"},{"key":"7256_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"7256_CR26","doi-asserted-by":"publisher","unstructured":"Kac PR et al (2022) Diagnostic value of serum versus plasma phospho-tau for Alzheimer\u2019s disease. Alzheimers Res Ther 14. https:\/\/doi.org\/10.1186\/s13195-022-01011-w","DOI":"10.1186\/s13195-022-01011-w"},{"key":"7256_CR27","doi-asserted-by":"publisher","first-page":"656750","DOI":"10.3389\/fnagi.2021.656750","volume":"13","author":"S Zhang","year":"2021","unstructured":"Zhang S et al (2021) Choriocapillaris changes are correlated with disease duration and MoCA score in early-onset dementia. Front Aging Neurosci 13:656750. https:\/\/doi.org\/10.3389\/fnagi.2021.656750","journal-title":"Front Aging Neurosci"},{"key":"7256_CR28","doi-asserted-by":"publisher","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie P et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 7:e34823. https:\/\/doi.org\/10.1371\/journal.pone.0034823","journal-title":"PLoS ONE"},{"key":"7256_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","volume":"97","author":"A Aytulun","year":"2021","unstructured":"Aytulun A et al (2021) APOSTEL 2.0 Recommendations for reporting quantitative optical coherence tomography studies. Neurology 97:68\u201379. https:\/\/doi.org\/10.1212\/WNL.0000000000012125","journal-title":"Neurology"},{"key":"7256_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.dadm.2019.05.002","volume":"11","author":"J den Haan","year":"2019","unstructured":"den Haan J et al (2019) Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer\u2019s disease. Alzh Dement-Dadm 11:463\u2013471. https:\/\/doi.org\/10.1016\/j.dadm.2019.05.002","journal-title":"Alzh Dement-Dadm"},{"key":"7256_CR31","doi-asserted-by":"publisher","first-page":"8826087","DOI":"10.1155\/2020\/8826087","volume":"2020","author":"L Jorge","year":"2020","unstructured":"Jorge L et al (2020) The retinal inner plexiform synaptic layer mirrors grey matter thickness of primary visual cortex with increased amyloid beta load in early Alzheimer\u2019s disease. Neural Plast 2020:8826087. https:\/\/doi.org\/10.1155\/2020\/8826087","journal-title":"Neural Plast"},{"key":"7256_CR32","doi-asserted-by":"publisher","unstructured":"Koronyo Y et al (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight 2. https:\/\/doi.org\/10.1172\/jci.insight.93621","DOI":"10.1172\/jci.insight.93621"},{"key":"7256_CR33","doi-asserted-by":"publisher","unstructured":"Ong YT et al (2015) Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci Lett 584:12\u201316. https:\/\/doi.org\/10.1016\/j.neulet.2014.10.010","DOI":"10.1016\/j.neulet.2014.10.010"},{"key":"7256_CR34","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1002\/alz.13086","volume":"19","author":"H Shi","year":"2023","unstructured":"Shi H et al (2023) Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients. Alzheimers Dement 19:5185\u20135197. https:\/\/doi.org\/10.1002\/alz.13086","journal-title":"Alzheimers Dement"},{"key":"7256_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"7256_CR36","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1212\/WNL.0b013e318281ccd3","volume":"80","author":"KK Leung","year":"2013","unstructured":"Leung KK et al (2013) Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 80:648\u2013654. https:\/\/doi.org\/10.1212\/WNL.0b013e318281ccd3","journal-title":"Neurology"},{"key":"7256_CR37","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3389\/fpsyt.2019.00953","volume":"10","author":"S Frenzel","year":"2019","unstructured":"Frenzel S et al (2019) A biomarker for Alzheimer\u2019s disease based on patterns of regional brain atrophy. Front Psychiatry 10:953. https:\/\/doi.org\/10.3389\/fpsyt.2019.00953","journal-title":"Front Psychiatry"},{"key":"7256_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/WNO.0000000000001657","volume":"43","author":"L Donaldson","year":"2023","unstructured":"Donaldson L, Chen M, Margolin E (2023) Transsynaptic ganglion cell degeneration in adult patients after occipital lobe stroke. J Neuroophthalmol 43:243\u2013247. https:\/\/doi.org\/10.1097\/WNO.0000000000001657","journal-title":"J Neuroophthalmol"},{"key":"7256_CR39","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp-2014-308189","volume":"86","author":"LJ Balk","year":"2015","unstructured":"Balk LJ et al (2015) Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. J Neurol Neurosurg Psychiatry 86:419\u2013424. https:\/\/doi.org\/10.1136\/jnnp-2014-308189","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7256_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajoc.2018.07.009","volume":"12","author":"A Martucci","year":"2018","unstructured":"Martucci A, Cesareo M, Nucci C, Mancino R (2018) Macular ganglion cells alteration in a patient with left homonymous hemianopia subsequent to surgical excision of an arteriovenous malformation. Am J Ophthalmol Case Rep 12:9\u201314. https:\/\/doi.org\/10.1016\/j.ajoc.2018.07.009","journal-title":"Am J Ophthalmol Case Rep"},{"key":"7256_CR41","doi-asserted-by":"publisher","first-page":"e12275","DOI":"10.1002\/dad2.12275","volume":"14","author":"Y Rotenstreich","year":"2022","unstructured":"Rotenstreich Y et al (2022) Thicker macula in asymptomatic APOE E4 middle-aged adults at high AD risk. Alzheimers Dement (Amst) 14:e12275. https:\/\/doi.org\/10.1002\/dad2.12275","journal-title":"Alzheimers Dement (Amst)"},{"key":"7256_CR42","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1001\/jamaophthalmol.2018.3556","volume":"136","author":"BE O'Bryhim","year":"2018","unstructured":"O\u2019Bryhim BE, Apte RS, Kung N, Coble D, Van Stavern GP (2018) Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol 136:1242\u20131248. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3556","journal-title":"JAMA Ophthalmol"},{"key":"7256_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/1567205012666150325182504","volume":"12","author":"R Antes","year":"2015","unstructured":"Antes R et al (2015) VEGF Mediates ApoE4-induced neovascularization and synaptic pathology in the choroid and retina. Curr Alzheimer Res 12:323\u2013334. https:\/\/doi.org\/10.2174\/1567205012666150325182504","journal-title":"Curr Alzheimer Res"},{"key":"7256_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","volume":"26","author":"PK Iseri","year":"2006","unstructured":"Iseri PK, Altina\u015f O, Tokay T, Y\u00fcksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26:18\u201324. https:\/\/doi.org\/10.1097\/01.wno.0000204645.56873.26","journal-title":"J Neuroophthalmol"},{"key":"7256_CR45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaophthalmol.2022.1563","volume":"140","author":"HM Kim","year":"2022","unstructured":"Kim HM et al (2022) Association between retinal layer thickness and cognitive decline in older adults. JAMA Ophthalmol 140:683\u2013690. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.1563","journal-title":"JAMA Ophthalmol"},{"key":"7256_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3233\/JAD-150438","volume":"49","author":"Z Shi","year":"2016","unstructured":"Shi Z et al (2016) The utilization of retinal nerve fiber layer thickness to predict cognitive deterioration. J Alzheimers Dis 49:399\u2013405. https:\/\/doi.org\/10.3233\/JAD-150438","journal-title":"J Alzheimers Dis"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07256-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T03:42:36Z","timestamp":1715312556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["7256"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07256-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Biomedical Research Ethics Committee and the Committee on Human Research of West China Hospital, Sichuan University (Ethics Number: 2020\u2013104). Informed consent was obtained from participants or their guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}